PRESS RELEASES

Date	Title and Summary	Additional Formats
Toggle SummaryApr 10, 2015	Integra LifeSciences to Host Its First Quarter 2015 Earnings Results Conference Call on April 30, 2015 PLAINSBORO, N.J., April 10, 2015 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) will release its first quarter 2015 financial results on Thursday, April 30, 2015, after the market closes. The company has scheduled a conference call for 4:30 PM ET the same day to discuss	View HTML Integra LifeSciences to Host Its First Quarter 2015 Earnings Results Conference Call on April 30, 2015 10 KB
Toggle SummaryApr 1, 2015	Integra LifeSciences Announces the Filing of the Form 10 Registration Statement for the Planned Spin-off of the Orthobiologics and Spinal Fusion Hardware Business, SeaSpine PLAINSBORO, N.J., April 1, 2015 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced the filing of an initial Form 10 Registration Statement with the Securities and Exchange Commission ("SEC") in connection with its previously announced plan to spin off	View HTML
Toggle SummaryFeb 24, 2015	Integra LifeSciences Reports Fourth Quarter 2014 Financial Results Revenues Increased 14.2% to $252.2 Million Organic Revenues Increased 5.8% Reported EPS Increased to $0.52; Adjusted EPS Increased to $0.94 Issues 2015 Full-Year Guidance PLAINSBORO, N.J., Feb. 24, 2015 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today reported its	View HTML Integra LifeSciences Reports Fourth Quarter 2014 Financial Results 61.6 KB
Toggle SummaryFeb 20, 2015	Integra LifeSciences to Participate in the Raymond James Institutional Investors Conference, Barclays Global Healthcare Conference and the Canaccord Genuity Musculoskeletal Conference in March PLAINSBORO, N.J., Feb. 20, 2015 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it will present at the following conferences in March: At 7:30AM ET on Monday, March 2, 2015, Glenn Coleman, Chief Financial Officer, will present at the Raymond James	View HTML Integra LifeSciences to Participate in the Raymond James Institutional Investors Conference, Barclays Global Healthcare Conference and the Canaccord Genuity Musculoskeletal Conference in March 10.8 KB
Toggle SummaryFeb 18, 2015	Marc H. Morial, President and CEO of the National Urban League, Will Speak at Integra LifeSciences Headquarters in Celebration of Black History Month PLAINSBORO, N.J., Feb. 18, 2015 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that the President and CEO of the National Urban League and former Mayor of New Orleans, Marc H. Morial, will be the keynote speaker at the Company's Plainsboro, NJ	View HTML Marc H. Morial, President and CEO of the National Urban League, Will Speak at Integra LifeSciences Headquarters in Celebration of Black History Month 13.6 KB
Toggle SummaryFeb 9, 2015	Integra LifeSciences to Participate in the RBC Capital Markets' Global Healthcare Conference PLAINSBORO, N.J., Feb. 9, 2015 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it will present at the following conference in February: At 11:30AM ET on Wednesday, February 25, 2015, Mr. Peter Arduini, Integra's President and Chief Executive Officer,	View HTML Integra LifeSciences to Participate in the RBC Capital Markets' Global Healthcare Conference 10.4 KB
Toggle SummaryFeb 3, 2015	Integra LifeSciences Announces Submission of a Premarket Approval Supplement Application for the Treatment of Diabetic Foot Ulcers PLAINSBORO, N.J., Feb. 3, 2015 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced it has completed the submission of a Premarket Approval (PMA) Supplement application to the United States Food and Drug Administration (the "FDA") for a new Indication of Use	View HTML Integra LifeSciences Announces Submission of a Premarket Approval Supplement Application for the Treatment of Diabetic Foot Ulcers 9.9 KB
Toggle SummaryJan 21, 2015	Integra LifeSciences Launches Integra(R) Reinforcement Matrix Designed for Use During Tendon Healing	View HTML Integra LifeSciences Launches Integra(R) Reinforcement Matrix 12 KB
Toggle SummaryJan 20, 2015	Integra LifeSciences Announces Resolution of Warning Letter Related to Its Manufacturing Facility in Anasco, Puerto Rico PLAINSBORO, N.J., Jan. 20, 2015 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced the United States Food and Drug Administration (the "FDA") has informed the Company that it had addressed the violations in the warning letter relating to its manufacturing	View HTML Integra LifeSciences Announces Resolution of Warning Letter Related to Its Manufacturing Facility in Anasco, Puerto Rico 9.7 KB
Toggle SummaryJan 14, 2015	Integra LifeSciences to Host Its Fourth Quarter 2014 Earnings Results Conference Call on February 24, 2015 PLAINSBORO, N.J., Jan. 14, 2015 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) will release its fourth quarter 2014 financial results and issue 2015 financial guidance on Tuesday, February 24, 2015. The company has scheduled a conference call for 8:30 AM ET the same day	View HTML Integra LifeSciences to Host Its Fourth Quarter 2014 Earnings Results Conference Call on February 24, 2015 10 KB
Toggle SummaryJan 12, 2015	Integra LifeSciences Acquires Metasurg's Foot and Ankle Product Portfolio PLAINSBORO, N.J., Jan. 12, 2015 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that, in December, it closed on the acquisition of the product portfolio from Metasurg. The addition of the Metasurg product portfolio enhances Integra's lower extremity	View HTML Integra LifeSciences Acquires Metasurg's Foot and Ankle Product Portfolio 12.2 KB
Toggle SummaryJan 5, 2015	Integra LifeSciences to Participate in the 33rd Annual J.P. Morgan Healthcare Conference in January PLAINSBORO, N.J., Jan. 5, 2015 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it will present at the 33 rd Annual J.P. Morgan Healthcare Conference. At 4:30PM PT on Wednesday, January 14, 2015, Mr. Peter Arduini, Integra's President and Chief	View HTML Integra LifeSciences to Participate in the 33rd Annual J.P. Morgan Healthcare Conference in January 13.4 KB
Toggle SummaryDec 17, 2014	Integra LifeSciences Launches Integra(R) Meshed Dermal Regeneration Template Expands Skin and Wound Product Line	View HTML Integra LifeSciences Launches Integra(R) Meshed Dermal Regeneration Template 12.7 KB
Toggle SummaryNov 20, 2014	Integra LifeSciences to Participate in the Piper Jaffray and Oppenheimer Healthcare Conferences in December PLAINSBORO, N.J., Nov. 20, 2014 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it will present at the following conferences in December: At 9:30AM ET on Tuesday, December 2, 2014, Mr. Glenn Coleman, Integra's Chief Financial Officer, will present at	View HTML Integra LifeSciences to Participate in the Piper Jaffray and Oppenheimer Healthcare Conferences in December 10.6 KB
Toggle SummaryNov 13, 2014	Integra LifeSciences Announces FDA Clearance and Controlled Market Release of Expandable Interbody System for Spinal Surgery PLAINSBORO, N.J., Nov. 13, 2014 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced the controlled market release of the Integra ® Expandable Interbody System, in the United States. The system, which received 510(k) clearance from the United States Food and	View HTML Integra LifeSciences Announces FDA Clearance and Controlled Market Release of Expandable Interbody System for Spinal Surgery 11.6 KB